NADPH oxidase inhibitor development for diabetic nephropathy through water tank modelopen access
- Authors
- Lee, H.E.; Shim, S.; Choi, Y.; Bae, Y.S.
- Issue Date
- 2022
- Publisher
- The Korean Society of Nephrology
- Keywords
- Diabetic nephropathies; NADPH oxidases; Nox inhibitor; Oxidative stress; Reactive oxygen species
- Citation
- Kidney Research and Clinical Practice, v.41, pp.S89 - S98
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Kidney Research and Clinical Practice
- Volume
- 41
- Start Page
- S89
- End Page
- S98
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/146995
- DOI
- 10.23876/j.krcp.21.269
- ISSN
- 2211-9132
- Abstract
- Oxidative stress can cause generation of uncontrolled reactive oxygen species (ROS) and lead to cytotoxic damage to cells and tissues. Recently, it has been shown that transient ROS generation can serve as a secondary messenger in receptor-mediated cell signaling. Although excessive levels of ROS are harmful, moderated levels of ROS are essential for normal physiological function. Therefore, regulating cellular ROS levels should be an important concept for development of novel therapeutics for treating diseases. The overexpression and hyperactivation of NADPH oxidase (Nox) can induce high levels of ROS, which are strongly associated with diabetic nephropathy. This review discusses the theoretical basis for development of the Nox inhibitor as a regulator of ROS homeostasis to provide emerging therapeutic opportunities for diabetic nephropathy. © 2022 by The Korean Society of Nephrology.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Life Sciences and Biotechnology > Division of Biotechnology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.